BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 24085852)

  • 21. Assembly and Function of the Anthrax Toxin Protein Translocation Complex.
    Liddington RC
    Subcell Biochem; 2021; 96():563-577. PubMed ID: 33252744
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Where and how do anthrax toxins exit endosomes to intoxicate host cells?
    Puhar A; Montecucco C
    Trends Microbiol; 2007 Nov; 15(11):477-82. PubMed ID: 17983750
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anthrax edema toxin impairs clearance in mice.
    Sastalla I; Tang S; Crown D; Liu S; Eckhaus MA; Hewlett IK; Leppla SH; Moayeri M
    Infect Immun; 2012 Feb; 80(2):529-38. PubMed ID: 22104108
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transcriptional stimulation of anthrax toxin receptors by anthrax edema toxin and Bacillus anthracis Sterne spore.
    Xu Q; Hesek ED; Zeng M
    Microb Pathog; 2007 Jul; 43(1):37-45. PubMed ID: 17459655
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumor endothelium marker-8 based decoys exhibit superiority over capillary morphogenesis protein-2 based decoys as anthrax toxin inhibitors.
    Cai C; Che J; Xu L; Guo Q; Kong Y; Fu L; Xu J; Cheng Y; Chen W
    PLoS One; 2011; 6(6):e20646. PubMed ID: 21674060
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Key tissue targets responsible for anthrax-toxin-induced lethality.
    Liu S; Zhang Y; Moayeri M; Liu J; Crown D; Fattah RJ; Wein AN; Yu ZX; Finkel T; Leppla SH
    Nature; 2013 Sep; 501(7465):63-8. PubMed ID: 23995686
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reduced cell migration and disruption of the actin cytoskeleton in calpain-deficient embryonic fibroblasts.
    Dourdin N; Bhatt AK; Dutt P; Greer PA; Arthur JS; Elce JS; Huttenlocher A
    J Biol Chem; 2001 Dec; 276(51):48382-8. PubMed ID: 11602605
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Contribution of lethal toxin and edema toxin to the pathogenesis of anthrax meningitis.
    Ebrahimi CM; Sheen TR; Renken CW; Gottlieb RA; Doran KS
    Infect Immun; 2011 Jul; 79(7):2510-8. PubMed ID: 21518787
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recombinant HSA-CMG2 Is a Promising Anthrax Toxin Inhibitor.
    Li L; Guo Q; Liu J; Zhang J; Yin Y; Dong D; Fu L; Xu J; Chen W
    Toxins (Basel); 2016 Jan; 8(1):. PubMed ID: 26805881
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Crystal structure of a complex between anthrax toxin and its host cell receptor.
    Santelli E; Bankston LA; Leppla SH; Liddington RC
    Nature; 2004 Aug; 430(7002):905-8. PubMed ID: 15243628
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human capillary morphogenesis protein 2 functions as an anthrax toxin receptor.
    Scobie HM; Rainey GJ; Bradley KA; Young JA
    Proc Natl Acad Sci U S A; 2003 Apr; 100(9):5170-4. PubMed ID: 12700348
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activity of the Bacillus anthracis 20 kDa protective antigen component.
    Hammamieh R; Ribot WJ; Abshire TG; Jett M; Ezzell J
    BMC Infect Dis; 2008 Sep; 8():124. PubMed ID: 18808698
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human genetic variation altering anthrax toxin sensitivity.
    Martchenko M; Candille SI; Tang H; Cohen SN
    Proc Natl Acad Sci U S A; 2012 Feb; 109(8):2972-7. PubMed ID: 22315420
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Receptor-enhanced immunogenicity of anthrax protective antigen is primarily mediated by capillary morphogenesis Protein-2.
    Verma A; Moayeri M; Mocca CP; O'Mard D; Ma Q; Leppla SH; Burns DL
    Vaccine; 2022 Jul; 40(32):4318-4321. PubMed ID: 35710508
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of a receptor-binding region within domain 4 of the protective antigen component of anthrax toxin.
    Varughese M; Teixeira AV; Liu S; Leppla SH
    Infect Immun; 1999 Apr; 67(4):1860-5. PubMed ID: 10085028
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular dynamics simulations of complexes between wild-type and mutant anthrax protective antigen variants and a model anthrax toxin receptor.
    Stiles L; Nelson DJ
    J Biomol Struct Dyn; 2005 Apr; 22(5):503-19. PubMed ID: 15702923
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantitative high-throughput screening identifies inhibitors of anthrax-induced cell death.
    Zhu PJ; Hobson JP; Southall N; Qiu C; Thomas CJ; Lu J; Inglese J; Zheng W; Leppla SH; Bugge TH; Austin CP; Liu S
    Bioorg Med Chem; 2009 Jul; 17(14):5139-45. PubMed ID: 19540764
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The dark sides of capillary morphogenesis gene 2.
    Deuquet J; Lausch E; Superti-Furga A; van der Goot FG
    EMBO J; 2012 Jan; 31(1):3-13. PubMed ID: 22215446
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A deleted variant of Bacillus anthracis protective antigen is non-toxic and blocks anthrax toxin action in vivo.
    Singh Y; Chaudhary VK; Leppla SH
    J Biol Chem; 1989 Nov; 264(32):19103-7. PubMed ID: 2509473
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The LDL receptor-related protein LRP6 mediates internalization and lethality of anthrax toxin.
    Wei W; Lu Q; Chaudry GJ; Leppla SH; Cohen SN
    Cell; 2006 Mar; 124(6):1141-54. PubMed ID: 16564009
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.